title: Safety of new oral anticoagulant drugs: a perspective.
abstract: The recent development of new oral anticoagulants (NOACs) offers the possibility of efficacy, relative safety and convenience compared with warfarin. This could lead to greater patient compliance, with easier management and improved provision of thromboprophylaxis. Safety whilst using NOACs should be focused on bleeding cases, surgery or on the management of patients receiving anticoagulant therapy with concomitant impairment of renal function, especially since many NOACs are dependent on renal excretion. Thus, if the clearance creatinine indicates severe renal impairment, NOACS will be contraindicated or their dose needs to be changed. In patients who need surgery, there are published protocols of management, depending on the severity of the intervention and renal function. In the case of severe hemorrhage, requiring rapid reversal of the anticoagulant effect and in the absence of specific antidotes, alternatives such as one of the nonspecific haemostatic agents must be considered. Clinical evaluation in bleeding situations and a meticulous risk-benefit appraisal for NOACs is needed, and these procoagulant agents and patients must be monitored closely. This article provides an overview of the pharmacology and potential risks, as well as the efficacy and safety of NOACs.
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK and Department of Cardiology and Department of Clinical Analysis, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
authors.forename: Juan Antonio
authors.initials: JA
authors.lastname: Vílchez
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK and Department of Hematology and Clinical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Gallego
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, UK.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
keywords: apixaban; bleeding; dabigatran; new oral anticoagulants; rivaroxaban
references.citation: Br J Clin Pharmacol. 2007 Sep;64(3):292-303
references.pmid: 17506785
references.citation: Stroke. 2011 Dec;42(12):3594-9
references.pmid: 21998060
references.citation: Drugs. 2012 Sep 10;72(13):1739-53
references.pmid: 22931521
references.citation: Clin Pharmacokinet. 2009;48(1):1-22
references.pmid: 19071881
references.citation: Drugs. 2012 Sep 10;72(13):1755-64
references.pmid: 22876779
references.citation: N Engl J Med. 2011 Sep 15;365(11):981-92
references.pmid: 21870978
references.citation: Chest. 2008 Jun;133(6 Suppl):454S-545S
references.pmid: 18574272
references.citation: J Trauma Acute Care Surg. 2012 Oct;73(4):983-92
references.pmid: 22976421
references.citation: Am J Respir Crit Care Med. 2013 Aug 15;188(4):413-21
references.pmid: 23672179
references.citation: Eur Heart J. 2013 Jun;34(22):1670-80
references.pmid: 23470494
references.citation: Thromb Haemost. 2011 Nov;106(5):868-76
references.pmid: 21946939
references.citation: N Engl J Med. 2013 Feb 7;368(6):513-23
references.pmid: 23388003
references.citation: Anesthesiology. 2012 Jan;116(1):94-102
references.pmid: 22042412
references.citation: Thromb Haemost. 2013 Apr;109(4):596-605
references.pmid: 23389759
references.citation: Circulation. 2009 Mar 17;119(10):1363-9
references.pmid: 19255343
references.citation: Blood. 2013 May 2;121(18):3554-62
references.pmid: 23476049
references.citation: Int J Clin Pract. 2013 Feb;67(2):139-56
references.pmid: 23305476
references.citation: J Clin Pharmacol. 2010 Jul;50(7):743-53
references.pmid: 20081065
references.citation: Thromb Haemost. 2012 May;107(5):838-47
references.pmid: 22318514
references.citation: Nat Med. 2013 Apr;19(4):446-51
references.pmid: 23455714
references.citation: Circulation. 2011 May 31;123(21):2363-72
references.pmid: 21576658
references.citation: Am J Health Syst Pharm. 2012 Oct 1;69(19):1646-50
references.pmid: 22997117
references.citation: Thromb Haemost. 2012 Aug;108(2):217-24
references.pmid: 22627883
references.citation: Lancet. 2010 Sep 18;376(9745):975-83
references.pmid: 20801496
references.citation: Circulation. 2012 Sep 25;126(13):1630-9
references.pmid: 22912386
references.citation: Circulation. 2011 Oct 4;124(14):1573-9
references.pmid: 21900088
references.citation: Thromb Haemost. 2010 Jun;103(6):1116-27
references.pmid: 20352166
references.citation: Clin Chem Lab Med. 2011 May;49(5):761-72
references.pmid: 21288169
references.citation: Chest. 2010 Nov;138(5):1093-100
references.pmid: 20299623
references.citation: J Thromb Thrombolysis. 2011 May;31(4):478-92
references.pmid: 21318583
references.citation: Chest. 2013 Nov;144(5):1555-1563
references.pmid: 23669885
references.citation: Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S
references.pmid: 19648146
references.citation: Blood Rev. 2011 Nov;25(6):271-8
references.pmid: 21872374
references.citation: N Engl J Med. 2011 Mar 3;364(9):806-17
references.pmid: 21309657
references.citation: Ann Pharmacother. 2013 Apr;47(4):573-7
references.pmid: 23548645
references.citation: J Thromb Haemost. 2011 Sep;9(9):1705-12
references.pmid: 21729240
references.citation: Thromb Haemost. 2012 Dec;108(6):1061-4
references.pmid: 22872143
references.citation: Blood. 2012 Oct 11;120(15):2954-62
references.pmid: 22932800
references.citation: Blood. 2012 Mar 1;119(9):2172-4
references.pmid: 22383791
references.citation: Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33
references.pmid: 22609214
references.citation: J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):595-604
references.pmid: 19571765
references.citation: Curr Hematol Rep. 2005 Sep;4(5):405-13
references.pmid: 16131443
references.citation: Thromb Haemost. 2011 Jul;106(1):156-64
references.pmid: 21655672
references.citation: Am Heart J. 2010 Jun;159(6):1102-7
references.pmid: 20569726
references.citation: Europace. 2012 Jan;14(1):8-27
references.pmid: 21791573
references.citation: Drugs. 2011 Oct 22;71(15):2079-89
references.pmid: 21985171
references.citation: Circulation. 2012 Nov 13;126(20):2428-32
references.pmid: 23147769
references.citation: Am J Cardiol. 2012 Aug 1;110(3):453-60
references.pmid: 22537354
references.citation: Curr Pharm Des. 2010;16(31):3436-41
references.pmid: 20858185
references.citation: Am Heart J. 2010 Mar;159(3):340-347.e1
references.pmid: 20211293
references.citation: Am Heart J. 2012 Jun;163(6):931-937.e1
references.pmid: 22709744
references.citation: J Am Coll Cardiol. 2012 Aug 21;60(8):738-46
references.pmid: 22575324
references.citation: Thromb Res. 2011 Jun;127(6):525-34
references.pmid: 21397931
references.citation: N Engl J Med. 2012 Apr 5;366(14):1287-97
references.pmid: 22449293
references.citation: N Engl J Med. 2011 Sep 8;365(10):883-91
references.pmid: 21830957
references.citation: Thromb Haemost. 2012 Oct;108(4):625-32
references.pmid: 22782297
references.citation: Thromb Haemost. 2011 Dec;106(6):997-1011
references.pmid: 22048796
references.citation: Ther Drug Monit. 2010 Dec;32(6):673-9
references.pmid: 20844464
references.citation: Circulation. 2012 Jul 17;126(3):343-8
references.pmid: 22700854
references.citation: Arch Intern Med. 2012 Nov 12;172(20):1537-45
references.pmid: 23007264
references.citation: J Am Coll Cardiol. 2013 Jun 4;61(22):2264-73
references.pmid: 23562920
references.citation: Chest. 2008 Jun;133(6 Suppl):381S-453S
references.pmid: 18574271
references.citation: Thromb Haemost. 2012 Feb;107(2):253-9
references.pmid: 22186946
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Orthop Traumatol Surg Res. 2012 Sep;98(5):484-90
references.pmid: 22542983
references.citation: Circulation. 2013 Jun 4;127(22):2166-76
references.pmid: 23640971
references.citation: Int J Emerg Med. 2009 Nov 26;2(4):217-25
references.pmid: 20436891
references.citation: Thromb Haemost. 2012 Nov;108(5):876-86
references.pmid: 23014816
references.citation: Neth J Med. 2010 Feb;68(2):68-76
references.pmid: 20167958